Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02193971
Recruitment Status : Recruiting
First Posted : July 18, 2014
Last Update Posted : March 9, 2018
Boston Scientific Korea Co. Ltd
Terumo Corporation
Information provided by (Responsible Party):
Seoul National University Hospital